Breaking News

Breaking news filtered in real-time to show only the most impactful headlines for US-listed public companies.

Lineage Announces Dosing of First Patient in New Clinical Study of OPC1 for Subacute and Chronic Spinal Cord Injury

CARLSBAD, Calif.--(BUSINESS WIRE)---- $LCTX #LineageCellTherapeutics--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogen...

What are the company’s projected costs for advancing the DOSED trial through Phase 2/3, and how will this affect runway and potential dilution? Are there any disclosed adverse events or safety signals from this first patient that could raise concerns among investors? What is the estimated market size for subacute and chronic spinal cord injury treatments, and what share can Lineage realistically capture if trials are successful?
Symbol: LCTX
Clinical trials
26 days ago
Read more businesswire

AT&T Expands Office@Hand Business Communications Portfolio with RingCX AI-Powered Contact Center and RingSense Conversational Intelligence Solutions by RingCentral

BELMONT, Calif. & DALLAS--(BUSINESS WIRE)---- $T #AI--RingCentral and AT&T unveil new additions to the AT&T Office@Hand portfolio

How does the expected contribution of this partnership to AT&T's earnings per share (EPS) guidance influence analyst sentiment? Will the partnership affect AT&T's relationships with existing enterprise customers or lead to new contract wins? What impact could this have on AT&T's long‑term growth strategy in the enterprise communications segment?
Symbol: T
Partnerships
26 days ago
Read more businesswire

GrabAGun Announces $20 Million Share Repurchase Authorization

COPPELL, Texas--(BUSINESS WIRE)--GrabAGun Digital Holdings Inc. (“GrabAGun” or the “Company”) (NYSE: PEW), an online retailer of firearms, ammunition and related accessories, today announced that i...

What tax considerations might institutional and retail investors face when participating in the share repurchase? Are there any regulatory or compliance considerations specific to a firearms retailer that could impact execution of the program? Does the board’s statement indicate a broader capital‑return strategy or a lack of alternative growth opportunities?
Symbol: PEW
Buyback
26 days ago
Read more businesswire

Genius Sports Secures Exclusive Official Data and Betting Streaming Rights with Lega Serie A Through 2029 to Power Next-Generation BetVision Product

MILAN & NEW YORK--(BUSINESS WIRE)--Genius Sports Limited (“Genius Sports”) (NYSE:GENI) has agreed an exclusive partnership with Serie A to capture, distribute and commercialize official data and lo...

Do analysts’ consensus estimates already factor in this deal, or will they need to be revised upward/downward after the announcement? How is the market likely to price the news event—will there be an immediate price reaction, or will the impact be gradual as financial benefits materialize? Will the partnership affect the company's customer acquisition cost (CAC) or churn rates among existing betting operators?
Symbol: GENI
Partnership
26 days ago
Read more businesswire

Macy’s Unveils First-Ever On 34th Collaboration

NEW YORK--(BUSINESS WIRE)--Macy’s announces its first-ever On 34th brand collaboration, in partnership with acclaimed costume designer Alix Friedberg and inspired by her work on the spirited world ...

How could the success or failure of this collaboration influence future designer partnerships for Macy’s? What are the inventory risk and supply‑chain considerations tied to this limited‑edition launch? Can the sales performance of the Palm Royale‑inspired collection be quantified on a per‑sku basis?
Symbol: M
Retail
26 days ago
Read more businesswire

Verint Celebrates Customer AI Adoption Milestone and Rings Nasdaq Opening Bell

MELVILLE, N.Y.--(BUSINESS WIRE)-- #AI--Verint¼ (NASDAQ: VRNT), The CX Automation Companyℱ, today celebrated its AI leadership in delivering meaningful, tangible AI business outcomes to customers by...

What risks could dampen the expected AI-driven revenue growth (e.g., churn, pricing pressure, competition)? How does Verint’s AI ARR growth affect its valuation multiples (e.g., EV/ARR) relative to peers? Is there any disclosed guidance on future AI ARR targets and their contribution to total ARR?
Symbol: VRNT
Earnings
26 days ago
Read more businesswire

Lincoln Electric Acquires Remaining Interest in Alloy Steel

CLEVELAND--(BUSINESS WIRE)-- #LEA--Lincoln Electric Holdings, Inc. (Nasdaq: LECO) (the “Company”) announced today that it has acquired the remaining 65% interest in Alloy Steel Australia (Int) Pty ...

Does the acquisition introduce any regulatory or compliance considerations that could affect Lincoln Electric’s operations in Australia or other markets? How did the market initially react to the announcement, and what is the expected price movement once the deal is reflected in the financial statements? What are the integration risks associated with fully absorbing Alloy Steel’s operations, and how is the company planning to mitigate them?
Symbol: LECO
Mergers
26 days ago
Read more businesswire

CommScope Reports Second Quarter 2025 Results

CLAREMONT, N.C.--(BUSINESS WIRE)-- #InvestorRelations--CommScope Holding Company, Inc. (NASDAQ: COMM), a global leader in network connectivity solutions, reported results for quarter ended June 30,...

How does CommScope’s performance position it against competitive pressure from legacy and emerging optical‑connectivity providers? Is there any impact from recent mergers, acquisitions, or divestitures on reported results? What macro‑economic factors (e.g., semiconductor shortage, supply‑chain disruptions) are highlighted as risks?
Symbol: COMM
Earnings
26 days ago
Read more businesswire

Twist Bioscience Announces Fiscal 2025 Third Quarter Financial Results

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth equity, today announced financial results and business highlights for the third quar...

What is the implied valuation impact of this earnings release on the stock’s price‑to‑sales, price‑to‑earnings, and other valuation multiples? Are there any risks or uncertainties highlighted in the release (e.g., supply‑chain constraints, regulatory changes, or competitive pressures) that could impact the stock? How did the company's guidance and outlook affect analyst sentiment and target price revisions?
Symbol: TWST
Earnings
26 days ago
Read more businesswire

Precision BioSciences to Report Second Quarter 2025 Results on August 7, 2025

DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUSÂź platform to develop in vivo gene editing ther...

How does Precision BioSciences’ valuation metrics (e.g., EV/Revenue, P/E, price/cash‑burn) compare to peer companies in the gene‑editing space? What are the potential short‑term catalysts (e.g., data releases, FDA meetings) that could move the stock after the August 7 announcement? Are there any material changes to the capital structure (e.g., stock issuances, debt financings, share buy‑backs) disclosed in the update?
Symbol: DTIL
Earnings
26 days ago
Read more businesswire